
CCT373567 demonstrates мощный and селективный BCL6 inhibition, exhibiting an IC50 of 2.9 nM in biochemical TR-FRET assays and 25.9 nM in клеточный NanoBRET assays. This клетка-permeable compound maintains robust activity in physiological settings, highlighting its potential as a targeted therapeutic agent.
CCT373567 demonstrates potent and selective BCL6 inhibition, exhibiting an IC50 of 2.9 nM in biochemical TR-FRET assays and 25.9 nM in cellular NanoBRET assays. This cell-permeable compound maintains robust activity in physiological settings, highlighting its potential as a targeted therapeutic agent.
Вращайте мышью · Колесо — масштаб
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.